Table 1.
Descriptive Characteristics of Transmasculine Sample (N=394)
Sociodemographics | Mean | SD |
---|---|---|
Age, continuous | ||
Range: 21–62 years | 32 | 9.4 |
N | % | |
---|---|---|
Race/Ethnicity | ||
American Indian or Alaska Native |
1 |
0.3 |
Asian |
15 |
3.8 |
Native Hawaiian or Pacific Islander |
0 |
0.0 |
Black or African American |
84 |
21.3 |
White |
229 |
58.1 |
Other |
48 |
12.2 |
Unknown or not reported |
17 |
4.3 |
Hispanic/Latinx | ||
Hispanic or Latinx |
46 |
11.7 |
Not Hispanic or Latinx |
239 |
60.7 |
Unknown or not reported |
109 |
27.7 |
Gender identity | ||
Transgender man |
359 |
91.1 |
Nonbinary, recorded female at birth |
35 |
8.9 |
Insurance | ||
No health insurance |
7 |
1.8 |
Public insurance (Medicaid, Medicare) |
92 |
23.4 |
Private, school or work insurance |
295 |
74.9 |
Sexual orientation and sexual partnering | ||
Sexual orientation |
|
|
Gay/homosexual/same-gender attracted |
43 |
10.9 |
Straight/heterosexual |
99 |
25.1 |
Bisexual |
27 |
6.9 |
Queer |
80 |
20.3 |
Other |
70 |
17.8 |
Unknown |
75 |
19.0 |
Gender of sexual partners |
|
|
Cisgender man |
92 |
23.4 |
Cisgender woman |
272 |
69.0 |
Transgender man |
61 |
15.5 |
Transgender woman |
39 |
9.9 |
Other |
39 |
9.9 |
Medical gender affirmation | ||
Hormone use | ||
Yes |
376 |
95.4 |
No |
18 |
4.6 |
Time on hormones |
n=376 |
|
Less than 6 months |
28 |
7.4 |
6 months to less than 12 months |
21 |
5.6 |
12 months to less than 3 years |
132 |
35.1 |
3 years to less than 5 years |
21 |
5.6 |
5 years or more |
90 |
23.9 |
Unknown | 84 | 22.3 |
SD, standard deviation.